
|Videos|April 29, 2022
ViaLase technology could impact glaucoma care for patients worldwide
Author(s)Kassi Filkins
Kevin Waltz, a consultant for ViaLase, discusses the company's technology: an image-guided femtosecond laser surgical system for the treatment of glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
2
Precise Bio completes procedure using PB-001, a 3D-bioprinted corneal implant
3
Corza Medical announces launch of the SensorTek ROP Kit
4
Defining Retinal Vascular Diseases AMD, DME, RVO
5


















































.png)


